These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8768719)

  • 21. Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain.
    Haddjeri N; Blier P
    Synapse; 1995 May; 20(1):54-67. PubMed ID: 7624830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies.
    Abellán MT; Jolas T; Aghajanian GK; Artigas F
    Synapse; 2000 Apr; 36(1):21-34. PubMed ID: 10700023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
    Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
    Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors.
    Tada K; Kasamo K; Suzuki T; Matsuzaki Y; Kojima T
    Hippocampus; 2004; 14(2):143-7. PubMed ID: 15098719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flattening plasma corticosterone levels increases the prevalence of serotonergic dorsal raphe neurons inhibitory responses to nicotine in adrenalectomised rats.
    Frías-Domínguez C; Garduño J; Hernández S; Drucker-Colin R; Mihailescu S
    Brain Res Bull; 2013 Sep; 98():10-22. PubMed ID: 23872451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A; Forster EA; Bill DJ; Brown G; Cliffe IA; Hartley JE; Jones DE; McLenachan A; Stanhope KJ; Critchley DJ; Childs KJ; Middlefell VC; Lanfumey L; Corradetti R; Laporte AM; Gozlan H; Hamon M; Dourish CT
    Behav Brain Res; 1996; 73(1-2):337-53. PubMed ID: 8788530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of 5-HT(1A) receptors in the phrenic nucleus of the rat attenuated raphe induced activation of the phrenic nerve activity.
    Pecotic R; Dogas Z; Valic Z; Valic M
    J Physiol Pharmacol; 2009 Sep; 60(3):167-72. PubMed ID: 19826196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
    Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus.
    Liu R; Jolas T; Aghajanian G
    Brain Res; 2000 Aug; 873(1):34-45. PubMed ID: 10915808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
    Matos FF; Korpinen C; Yocca FD
    Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.
    Defraiteur C; Plenevaux A; Scuvée-Moreau J; Rouchet N; Goblet D; Luxen A; Seutin V
    Br J Pharmacol; 2007 Nov; 152(6):952-8. PubMed ID: 17704821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones.
    Craven R; Grahame-Smith D; Newberry N
    Eur J Pharmacol; 1994 Dec; 271(1):R1-3. PubMed ID: 7698189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
    Sprouse J; Braselton J; Reynolds L
    Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.
    Harsing LG; Prauda I; Barkoczy J; Matyus P; Juranyi Z
    Neurochem Res; 2004 Aug; 29(8):1487-97. PubMed ID: 15260125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence.
    Kasamo K; Suzuki T; Tada K; Ueda N; Matsuda E; Ishikawa K; Kojima T
    Neuropsychopharmacology; 2001 Feb; 24(2):141-51. PubMed ID: 11120396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
    J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.
    Zhang QJ; Gao R; Liu J; Liu YP; Wang S
    Sheng Li Xue Bao; 2007 Apr; 59(2):183-9. PubMed ID: 17437041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
    Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
    Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.